Morrison et al v. Teva Branded Pharmaceutical Products R&D, Inc. et al
| Melissa Morrison, Kellie Valencia and Karie Kuehl |
| Teva Branded Pharmaceutical Products R&D, Inc., Janssen Research & Development LLC, Jansen Pharmaceuticals, Inc., Teva Global Respiratory Research, LLC, Teva Pharmaceuticals USA, Inc., Alza Corporation, Johnson & Johnson Research & Development, L.L.C., Ortho-McNeil Pharmaceutical, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Janseen Ortho LLC, Johnson & Johnson, Dr. C. Lowell Parsons, MD and Does 1-20 |
| 3:2022cv01074 |
| July 22, 2022 |
| US District Court for the Southern District of California |
| Michael S Berg |
| Gonzalo P Curiel |
| Personal Inj. Prod. Liability |
| 28 U.S.C. § 1332 pi Diversity-Personal Injury |
| Defendant |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 18, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 15
Order Denying Defendants' Ex Parte Application for an Expedited Briefing Schedule; Setting Briefing Schedule for the Defendants' Motion to Stay; and Resetting Hearing on Plaintiffs' Motion for Remand (ECF Nos. #8 , #9 ). Signed by Judge Gonzalo P. Curiel on 9/2/2022. (jrm)
|
|
Filing 14
Order Extending Time to Answer or Otherwise Respond to the Complaint (ECF No. #11 ). Defendants' last day to answer or otherwise respond to Plaintiffs' Complaint shall set for 30 days following the JPMLs decision on the Motion to Vacate the Conditional Transfer Order. Signed by Judge Gonzalo P. Curiel on 8/29/22.(jmo)
|
| Filing 13 RESPONSE in Support re #8 Ex Parte MOTION to Shorten Time for an Expedited Briefing Schedule for Motion to Stay All Proceedings Pending Ruling by the Judicial Panel on Multidistrict Litigation; Declaration of Matthew K. Ashby filed by Alza Corporation, Janseen Ortho LLC, Jansen Pharmaceuticals, Inc., Janssen Research & Development LLC, Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc.. (Ashby, Matthew) (jmo). |
| Filing 12 RESPONSE in Opposition re #8 Ex Parte MOTION to Shorten Time for an Expedited Briefing Schedule for Motion to Stay All Proceedings Pending Ruling by the Judicial Panel on Multidistrict Litigation; Declaration of Matthew K. Ashby filed by Karie Kuehl, Melissa Morrison, Kellie Valencia. (Rodriguez, Christopher) (jmo). |
| Filing 11 Joint MOTION for Extension of Time to File Answer (Stipulation and Order re Extension of Time to Answer or Otherwise Respond to Complaint) by Alza Corporation, Janseen Ortho LLC, Jansen Pharmaceuticals, Inc., Janssen Research & Development LLC, Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc.. (Ashby, Matthew) 2 (jmo). Modified on 8/31/2022 (jmo). |
|
Filing 10
Order Setting Briefing Schedule on Defendants' Ex Parte Application for an Expedited Briefing Schedule (ECF No. #8 ). Any opposition shall be filed on or before Monday, 8/29/2022. Any reply shall be filed on or before Wednesday, 8/31/2022. Signed by Judge Gonzalo P. Curiel on 8/25/22.(jmo)
|
| Filing 9 MOTION to Remand by Karie Kuehl, Melissa Morrison, Kellie Valencia. (Attachments: #1 Memo of Points and Authorities, #2 Declaration of Melissa Morrison, #3 Declaration of Karie Kuehl)(Rodriguez, Christopher) (jmo). |
| Filing 8 Ex Parte MOTION to Shorten Time for an Expedited Briefing Schedule for Motion to Stay All Proceedings Pending Ruling by the Judicial Panel on Multidistrict Litigation; Declaration of Matthew K. Ashby by Alza Corporation, Janseen Ortho LLC, Jansen Pharmaceuticals, Inc., Janssen Research & Development LLC, Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc. (Attachments: #1 Exhibit A)(Ashby, Matthew) (jmo). |
| Filing 7 MOTION to Stay All Proceedings Pending Ruling By The Judicial Panel on Multidistrict Litigation by Alza Corporation, Janseen Ortho LLC, Jansen Pharmaceuticals, Inc., Janssen Research & Development LLC, Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Declaration of Matthew K. Ashby, #2 Exhibit A, #3 Exhibit B)(Ashby, Matthew)Attorney Matthew Kenneth Ashby added to party Jansen Pharmaceuticals, Inc.(pty:dft) (jmo). |
|
Filing 6
Order Granting Defendants' Motion to Extend Time for Defendants to Answer, Plead or Otherwise Respond to Complaint (ECF No. #5 ). Signed by Judge Gonzalo P. Curiel on 8/1/2022. (jrm)
|
| Filing 5 MOTION for Extension of Time to File Answer Plead or Otherwise Respond to Complaint by Alza Corporation, Janseen Ortho LLC, Jansen Pharmaceuticals, Inc., Janssen Research & Development LLC, Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc. (Attachments: #1 Exhibit A)(Romano, Julia)(jrm). |
| Filing 4 NOTICE of Party With Financial Interest by Alza Corporation, Janseen Ortho LLC, Jansen Pharmaceuticals, Inc., Janssen Research & Development LLC, Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc. re #3 Notice of Related Case, #2 Corporate Disclosure Statement,, #1 Notice of Removal,, . No Parties With Financial Interest. (Romano, Julia)(jrm). |
| Filing 3 NOTICE OF RELATED CASE(S) by Alza Corporation, Janseen Ortho LLC, Jansen Pharmaceuticals, Inc., Janssen Research & Development LLC, Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc. of case(s) 20-md-02973 re #2 Corporate Disclosure Statement,, #1 Notice of Removal, . (Attachments: #1 Exhibit A)(Romano, Julia)(jrm). |
| Filing 2 Corporate Disclosure Statement by Alza Corporation, Janseen Ortho LLC, Jansen Pharmaceuticals, Inc., Janssen Research & Development LLC, Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc. identifying Other Affiliate Teva Branded Pharmaceutical Products R&D, Inc. for Alza Corporation, Janseen Ortho LLC, Jansen Pharmaceuticals, Inc., Janssen Research & Development LLC, Ortho-McNeil Pharmaceutical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc.; Corporate Parent Johnson & Johnson for Johnson & Johnson. (Romano, Julia) |
| Filing 1 NOTICE OF REMOVAL with Jury Demand (Filing fee $402 - receipt number ACASDC-17017075), filed by Janseen Ortho LLC, Jansen Pharmaceuticals, Inc., Ortho-McNeil Pharmaceutical, Inc., Johnson & Johnson, Teva Pharmaceuticals USA, Inc., Alza Corporation, Janssen Research & Development LLC, Teva Branded Pharmaceutical Products R&D, Inc.. (Attachments: #1 Civil Cover Sheet, #2 Exhibit A-Complaint)The new case number is 3:22-cv-1074-GPC-MSB. Judge Gonzalo P. Curiel and Magistrate Judge Michael S. Berg are assigned to the case.(jms) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the California Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
